Sign in to check this stock against your screeners
Sign InUS45337C1027Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in...
$175.30
1D:
4.2%
1Y:
10.9%
US09062X1037Mkt Cap
$25.72B
P/E Ratio TTM
20.1
Revenue TTM
$9.81B
Beta
0.16
Earnings TTM
$1.29B
Dividend Yield TTM
0.00%
$572.20
1D:
-1.6%
1Y:
91.6%
US91307C1027Mkt Cap
$25.08B
P/E Ratio TTM
18.9
Revenue TTM
$3.18B
Beta
0.75
Earnings TTM
$1.33B
Dividend Yield TTM
0.00%
This company does not pay dividends